Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 12 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Organic light emitting display device and method of manufacturing the same
Area efficient through-hole connections
Mono-body defibrillation probe
Method and system for security authentication of radio frequency identification
Down-drawable, chemically strengthened glass for cover plate
Method for exchanging data concerning an electronic transaction
Methods, systems, and media for swapping faces in images
  Randomly Featured Patents
Apparatus and method for providing mechanically pre-formed conductive leads
Intermodal container with integrated interbox connectors
Pyridine derivatives
Numeric based addressing for enhanced telephony and multimedia services
Computer system and method for customizing context information sent with document fragments across a computer network
Tissue hydration estimation by spectral absorption bandwidth measurement
Methods for reducing gluconoylation of proteins
Splice housing apparatus
Thermal ink transfer printing apparatus
Collar for mounting a split saw blade on an arbor